Shineco Inc. Expands with New Biological Cell Digital Division to Integrate Blockchain Technology

Reuters
08/13
Shineco Inc. Expands with New Biological Cell Digital Division to Integrate Blockchain Technology

Shineco Inc., a NASDAQ-listed manufacturer specializing in induced pluripotent stem cell technology, has announced the creation of a new Biological Cell Digital Business Division. This strategic move aims to integrate its biological cell assets with blockchain technology to enhance global distribution and sales. Appointed as General Manager, Mr. Lin Hongguang, formerly of the Korea Digital Currency Research Institute, will lead the division's efforts to build a blockchain-based ecosystem within the biological cell sector. The initiative seeks to address industry challenges by enabling cross-regional collaboration and improving access to cell technology services. The company sees this development as a pivotal element of its growth strategy, poised to increase global market share and shareholder value.

Disclaimer: This news brief was created by Public Technologies (PUBT) using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Shineco Inc. published the original content used to generate this news brief via PR Newswire (Ref. ID: CN50586) on August 13, 2025, and is solely responsible for the information contained therein.

免责声明:投资有风险,本文并非投资建议,以上内容不应被视为任何金融产品的购买或出售要约、建议或邀请,作者或其他用户的任何相关讨论、评论或帖子也不应被视为此类内容。本文仅供一般参考,不考虑您的个人投资目标、财务状况或需求。TTM对信息的准确性和完整性不承担任何责任或保证,投资者应自行研究并在投资前寻求专业建议。

热议股票

  1. 1
     
     
     
     
  2. 2
     
     
     
     
  3. 3
     
     
     
     
  4. 4
     
     
     
     
  5. 5
     
     
     
     
  6. 6
     
     
     
     
  7. 7
     
     
     
     
  8. 8
     
     
     
     
  9. 9
     
     
     
     
  10. 10